Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia

ClinicalTrials.gov ID: NCT01963598

Public ClinicalTrials.gov record NCT01963598. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, multicenter phase 2 study of the safety and efficacy of 3-month subcutaneous (SC) REGN1033 (SAR391786) treatment in patients with sarcopenia.

Study identification

NCT ID
NCT01963598
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
253 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Jan 2015 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
Mar 28, 2016

2013 – 2015

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Not listed Anniston Alabama — —
Not listed Phoenix Arizona — —
Not listed El Cajon California — —
Not listed Garden Grove California — —
Not listed Laguna Hills California — —
Not listed San Francisco California — —
Not listed Walnut Creek California — —
Not listed Aurora Colorado — —
Not listed Gainesville Florida — —
Not listed Jacksonville Florida — —
Not listed Jupiter Florida — —
Not listed Orlando Florida — —
Not listed South Miami Florida — —
Not listed Chicago Illinois — —
Not listed Baton Rouge Louisiana — —
Not listed College Park Maryland — —
Not listed Elkridge Maryland — —
Not listed Boston Massachusetts — —
Not listed Edina Minnesota — —
Not listed Omaha Nebraska — —
Not listed Albuquerque New Mexico — —
Not listed High Point North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Athens Ohio — —
Not listed Columbus Ohio — —
Not listed Duncansville Pennsylvania — —
Not listed Spartanburg South Carolina — —
Not listed Dallas Texas — —
Not listed Plano Texas — —
Not listed San Antonio Texas — —
Not listed Salt Lake City Utah — —
Not listed West Jordan Utah — —
Not listed Richmond Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01963598, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01963598 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →